Atom Investors LP purchased a new stake in shares of Inari Medical, Inc. (NASDAQ:NARI) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 77,552 shares of the company’s stock, valued at approximately $3,757,000. Atom Investors LP owned 0.17% of Inari Medical as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Nwam LLC bought a new stake in Inari Medical during the 2nd quarter worth approximately $388,000. Clean Yield Group purchased a new stake in shares of Inari Medical in the second quarter worth $28,000. First Trust Advisors LP purchased a new position in Inari Medical during the second quarter worth about $2,756,000. Janney Montgomery Scott LLC purchased a new stake in shares of Inari Medical in the 2nd quarter valued at about $978,000. Finally, Emerald Advisers LLC bought a new stake in shares of Inari Medical during the 2nd quarter valued at about $484,000. Institutional investors own 15.23% of the company’s stock.
Several equities research analysts have issued reports on the stock. Canaccord Genuity lifted their target price on shares of Inari Medical from $60.00 to $73.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Wells Fargo & Co initiated coverage on shares of Inari Medical in a research report on Tuesday, June 16th. They issued an “equal weight” rating and a $49.00 target price for the company. Zacks Investment Research downgraded Inari Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, August 26th. Bank of America began coverage on Inari Medical in a report on Tuesday, June 16th. They issued a “neutral” rating and a $56.00 price objective for the company. Finally, Morgan Stanley increased their price objective on Inari Medical from $52.00 to $66.00 and gave the company an “equal weight” rating in a research report on Wednesday, August 12th. Four investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $64.60.
Inari Medical stock traded down $0.47 during trading hours on Friday, reaching $71.17. The company had a trading volume of 419,400 shares, compared to its average volume of 310,628. The company has a debt-to-equity ratio of 0.16, a current ratio of 20.16 and a quick ratio of 19.64. The stock has a 50-day simple moving average of $64.67. Inari Medical, Inc. has a 12-month low of $39.55 and a 12-month high of $84.91.
Inari Medical (NASDAQ:NARI) last posted its quarterly earnings results on Tuesday, August 11th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.02. The company had revenue of $25.40 million during the quarter, compared to analysts’ expectations of $12.97 million. The firm’s revenue was up 151.5% on a year-over-year basis. Sell-side analysts expect that Inari Medical, Inc. will post -0.06 earnings per share for the current fiscal year.
About Inari Medical
There is no company description available for Inari Medical Inc
Further Reading: What is the strike price in options trading?
Receive News & Ratings for Inari Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inari Medical and related companies with MarketBeat.com's FREE daily email newsletter.